A role for mitochondrial enzymes in inherited neoplasia and beyond
暂无分享,去创建一个
Charis Eng | L. Aaltonen | C. Eng | Lauri A. Aaltonen | Maija Kiuru | Magalí Fernández | Magali J. Fernandez | M. Kiuru
[1] B. Devlin,et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.
[2] D. Clayton,et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC , 1994, Nature Genetics.
[3] L. Aaltonen,et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Nomoto,et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids , 2001, Oncogene.
[5] B. Baysal. Hereditary paraganglioma targets diverse paraganglia , 2002, Journal of medical genetics.
[6] A. Munnich,et al. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. , 2000, American journal of human genetics.
[7] R. Seruca,et al. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma , 2001, Genes, chromosomes & cancer.
[8] Y Li,et al. [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].
[9] B. Lemire,et al. The Quinone-binding Sites of the Saccharomyces cerevisiae Succinate-ubiquinone Oxidoreductase* , 2001, The Journal of Biological Chemistry.
[10] G. Kroemer,et al. NADH Oxidase Activity of Mitochondrial Apoptosis-inducing Factor* , 2001, The Journal of Biological Chemistry.
[11] Sophia Tsoka,et al. Prediction of protein interactions: metabolic enzymes are frequently involved in gene fusion , 2000, Nature Genetics.
[12] G. Kroemer,et al. Redox activity of AIF 1 Mo : 10498 NADH-oxidase activity of mitochondrial apoptosis-inducing factor ( AIF ) , 2001 .
[13] P. Vandenabeele,et al. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet , 2002, Cell Death and Differentiation.
[14] B. Ackrell. Progress in understanding structure–function relationships in respiratory chain complex II , 2000, FEBS letters.
[15] D. Leigh. SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANT , 1951, Journal of neurology, neurosurgery, and psychiatry.
[16] B. Delahunt,et al. RENAL CELL NEOPLASIA , 2002, Pathology.
[17] A. Munnich,et al. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome , 2000, Human Genetics.
[18] E Gabrielson,et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. , 2001, Cancer research.
[19] A. Paetau,et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.
[20] A. Cheung,et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. , 2001, Cancer research.
[21] P. Bénit,et al. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. , 2001, American journal of human genetics.
[22] C. Eng,et al. The pressure rises: update on the genetics of phaeochromocytoma. , 2002, Human molecular genetics.
[23] Bert Vogelstein,et al. Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.
[24] A. Munnich,et al. Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. , 1994, The Journal of clinical investigation.
[25] A. Vinogradov,et al. On the possible interrelations of the reactivity of soluble succinate dehydrogenase with ferricyanide, reconstitution activity, and the Hipip iron sulfur center. , 1975, Biochemical and biophysical research communications.
[26] E S Husebye,et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.
[27] W. Rubinstein,et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas , 2002, Journal of medical genetics.
[28] C Eng,et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. , 1996, JAMA.
[29] E. Mariman,et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy , 1999, Nature Genetics.
[30] The subunit interactions of fumarase. , 1971, The Journal of biological chemistry.
[31] C. Eng,et al. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. , 2000, Cancer research.
[32] P. Kaplan,et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene , 1999, Nature Genetics.
[33] J. Arias-Stella,et al. Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance. , 1976, Human pathology.
[34] E. Mariman,et al. Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. , 1998, American journal of human genetics.
[35] P. Rustin,et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. , 2001, American journal of human genetics.
[36] J. Weber,et al. A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. , 1992, Human molecular genetics.
[37] S. Weis,et al. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples , 2001, International Journal of Cancer.
[38] A. Kroll,et al. HEREDITARY DEFICIENCIES OF CLOTTING FACTORS VII AND X ASSOCIATED WITH CAROTID-BODY TUMORS. , 1964, The New England journal of medicine.
[39] B. Delahunt,et al. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. , 2002, Cancer research.
[40] P. Barth,et al. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I , 1999, Annals of neurology.
[41] M. Saghbini,et al. The C-terminus of the succinate dehydrogenase IP peptide of Saccharomyces cerevisiae is significant for assembly of complex II. , 1992, Biochemistry.
[42] L. Aaltonen,et al. Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. , 2001, The American journal of pathology.
[43] M. Ivan,et al. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. , 2001, Human molecular genetics.
[44] P. Ratcliffe,et al. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease. , 2001, Human molecular genetics.
[45] J. Strauchen. Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.
[46] P. Maaswinkel-Mooy,et al. GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY , 1989, The Lancet.
[47] J. López-Barneo,et al. Cellular mechanism of oxygen sensing. , 2001, Annual review of physiology.
[48] R. Houlston,et al. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. , 2001, American journal of human genetics.
[49] J. Gnarra,et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.
[50] P. Devilee,et al. Further Localization of the Gene for Hereditary Paragangliomas and Evidence for Linkage in Unrelated Families , 1994, European journal of human genetics : EJHG.
[51] K. Lunetta,et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours , 2000, Oncogene.
[52] Ulrich Müller,et al. Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.
[53] E. Bertini,et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. , 1998, American journal of human genetics.
[54] B. Hamel,et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. , 1998, American journal of human genetics.
[55] D. Rees,et al. Structure of the Escherichia coli fumarate reductase respiratory complex. , 1999, Science.
[56] P. Rustin,et al. Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. , 2002, The Journal of clinical endocrinology and metabolism.
[57] G. Kroemer,et al. Mitochondria, the killer organelles and their weapons , 2002, Journal of cellular physiology.
[58] A. Munnich,et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure , 2001, Nature Genetics.
[59] A. Munnich,et al. A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency. , 2000, Human molecular genetics.
[60] H. Mandel,et al. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy , 2001, Annals of neurology.
[61] N. Chandel,et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. , 1998, Proceedings of the National Academy of Sciences of the United States of America.